In lung cancer, therefore, loss of BRG1 is associated with increased immunoproteasome expression and increased levels of aneuploidy, which is consistent with the possibility that changes in tolerance pathways due to BRG1 loss might contribute to the survival of aneuploid cells during cancer progression. Here, SMARCA4 is linked to cancer.